CREATe-1
Publication - Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study

We're thrilled to share that our latest research, "Chemogenetic Inhibition of the Lateral Hypothalamus Effectively Reduces Food Intake in Rats in a Translational Proof-of-Concept Study," has been published in Scientific Reports - Nature!

The study validates a robust and simple in vivo assay in rats, supporting the progression of our chemogenetic drug discovery project. It introduces a reliable model for preclinical proof-of-concept studies to measure the in vivo efficacy of newly developed chemogenetic treatments in rats. In addition, the paper highlights the potential of chemogenetic treatments as an effective new strategy to influence food intake and combat obesity.

Read the full article here: https://rdcu.be/dIj7G.

The study and publication were developed in collaboration with esteemed researchers Péter Kovács, Tamás Kitka, Zsolt Bali, Lili Veronika Nagy, Angelika Bodó, Tamás Kovács-Öller, Zalán Péterfi, and István Hernádi.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
May 24, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
May 24, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Team
June 11, 2024
By VRG Therapeutics
VRG Therapeutics among the top 30 startups to participate in the Labena Ventures Accelerator Program!
White arrow icon up and right direction redirecting to Partner with US page
Conference
May 22, 2024
By VRG Therapeutics
BIO 2024 San Diego
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Team
June 11, 2024
By VRG Therapeutics
VRG Therapeutics among the top 30 startups to participate in the Labena Ventures Accelerator Program!
White arrow icon up and right direction redirecting to Partner with US page
Conference
May 22, 2024
By VRG Therapeutics
BIO 2024 San Diego
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life